# Diffuse panbronchiolitis as a rare complication of thymectomy and radiation therapy in a patient with thymoma: a case report

**Authors:** Ye Lu, Qi Qi, Dan Qu, Yu Chen

PMC · DOI: 10.3389/fonc.2025.1496693 · Frontiers in Oncology · 2025-01-30

## TL;DR

A 47-year-old man with thymoma developed diffuse panbronchiolitis (DPB) after thymectomy and radiation therapy, which improved with azithromycin and steroids.

## Contribution

This case report highlights DPB as a rare complication of thymectomy and radiation therapy in thymoma patients with immune deficiency.

## Key findings

- DPB and radiation pneumonitis occurred in a thymoma patient after thymectomy and radiation therapy.
- Low-dose azithromycin and glucocorticoids improved symptoms and lung imaging findings.
- CD4+ T cell immunodeficiency was observed despite normal immunoglobulin levels.

## Abstract

Diffuse panbronchiolitis (DPB) is an uncommon respiratory disorder characterized by the presence of respiratory bronchiolitis and persistent inflammation in adjacent tissues, which can be effectively treated with early diagnosis and intervention. DPB is a rare complication associated with thymoma that remains poorly understood, especially when it occurs in conjunction with acquired cellular immune deficiency.

We present a case of DPB in a patient with thymoma following thymectomy and radiation therapy. A 47-year-old Chinese man underwent thymectomy due to the presence of a mediastinal mass, and pathological examination confirmed a type B2 thymoma. He also underwent 25 sessions of radiation therapy. The patient’s respiratory symptoms, including cough, expectoration, and shortness of breath, worsened significantly after radiation treatment. Immune dysfunction, marked by CD4+ T cell immunodeficiency with normal immunoglobulin levels, was observed. Chest computed tomography revealed diffuse nodules with tree-in-bud signs and new consolidation within the irradiated area, leading to a diagnosis of combined DPB and radiation pneumonitis. The patient’s symptoms and lung imaging findings significantly improved after the initiation of low-dose oral azithromycin for DPB and low-dose glucocorticoid therapy for radiation pneumonitis.

Clinicians should consider DPB in patients with thymoma and cellular immunodeficiency. Both thymectomy and radiation therapy can contribute to the development of DPB. Early treatment with macrolides can improve patient prognosis.

## Linked entities

- **Chemicals:** azithromycin (PubChem CID 447043)
- **Diseases:** diffuse panbronchiolitis (MONDO:0011490), thymoma (MONDO:0006456), radiation pneumonitis (MONDO:0043919)

## Full-text entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}
- **Diseases:** inflammation (MESH:D007249), cough (MESH:D003371), shortness of breath (MESH:D004417), Immune dysfunction (MESH:D007154), radiation pneumonitis (MESH:D017564), respiratory symptoms (MESH:D012818), B2 thymoma (MESH:D013945), respiratory disorder (MESH:D012131), cellular immune deficiency (MESH:D007153), respiratory bronchiolitis (MESH:D001988), DPB (MESH:C536174)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11821482/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11821482/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC11821482/full.md

---
Source: https://tomesphere.com/paper/PMC11821482